Chevy Chase Trust’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Sell |
25,943
-875
| -3% | -$133K | 0.01% | 533 |
|
|
2025
Q1 | $4.04M | Sell |
26,818
-16
| -0.1% | -$2.41K | 0.01% | 534 |
|
|
2024
Q4 | $4.95M | Sell |
26,834
-849
| -3% | -$157K | 0.02% | 510 |
|
|
2024
Q3 | $5.45M | Sell |
27,683
-447
| -2% | -$88K | 0.02% | 499 |
|
|
2024
Q2 | $5.81M | Sell |
28,130
-283
| -1% | -$58.5K | 0.02% | 479 |
|
|
2024
Q1 | $7.7M | Sell |
28,413
-242
| -0.8% | -$65.6K | 0.03% | 452 |
|
|
2023
Q4 | $6.77M | Sell |
28,655
-166
| -0.6% | -$39.2K | 0.02% | 463 |
|
|
2023
Q3 | $5.65M | Sell |
28,821
-624
| -2% | -$122K | 0.02% | 471 |
|
|
2023
Q2 | $6.19M | Sell |
29,445
-122
| -0.4% | -$25.7K | 0.02% | 472 |
|
|
2023
Q1 | $5.97M | Buy |
29,567
+303
| +1% | +$61.2K | 0.02% | 477 |
|
|
2022
Q4 | $6.38M | Sell |
29,264
-1,795
| -6% | -$391K | 0.03% | 462 |
|
|
2022
Q3 | $6.11M | Buy |
31,059
+377
| +1% | +$74.2K | 0.03% | 460 |
|
|
2022
Q2 | $6.57M | Buy |
30,682
+342
| +1% | +$73.2K | 0.03% | 463 |
|
|
2022
Q1 | $8.62M | Buy |
30,340
+43
| +0.1% | +$12.2K | 0.03% | 449 |
|
|
2021
Q4 | $11.4M | Sell |
30,297
-659
| -2% | -$248K | 0.04% | 392 |
|
|
2021
Q3 | $12.8M | Sell |
30,956
-1,078
| -3% | -$445K | 0.04% | 357 |
|
|
2021
Q2 | $11.8M | Buy |
+32,034
| New | +$11.8M | 0.04% | 385 |
|
|
2020
Q1 | – | Sell |
-593
| Closed | -$91K | – | 708 |
|
|
2019
Q4 | $91K | Buy |
+593
| New | +$91K | ﹤0.01% | 735 |
|